Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

131 results about "Amputation" patented technology

Amputation is the removal of a limb by trauma, medical illness, or surgery. As a surgical measure, it is used to control pain or a disease process in the affected limb, such as malignancy or gangrene. In some cases, it is carried out on individuals as a preventative surgery for such problems. A special case is that of congenital amputation, a congenital disorder, where fetal limbs have been cut off by constrictive bands. In some countries, amputation of the hands, feet or other body parts is or was used as a form of punishment for people who committed crimes. Amputation has also been used as a tactic in war and acts of terrorism; it may also occur as a war injury. In some cultures and religions, minor amputations or mutilations are considered a ritual accomplishment.

Active-passive type ankle joint prosthesis and movement mode thereof

ActiveCN102973338AMeet normal walking requirementsArtificial legsCarbon fibersCoronal plane
The invention discloses an active-passive type two-degrees-of freedom ankle joint prosthesis, comprising a carbon fiber energy storage sole, a motor, a speed reducer, a motor fixing supporting seat, a belt pulley transmission device, a carbon fiber pipe, a ball screw, an energy storage springs, joint bearings, energy storage rubber rings and joint supporting seats, wherein the carbon fiber energy storage sole is connected with the carbon fiber pipe through the joint supporting seats; the motor fixing supporting seat is connected with the carbon fiber pipe through an active pin; the motor is fixedly arranged on one end of the motor fixing supporting seat; the ball screw is fixedly arranged on the other end of the motor fixing supporting seat; two ends of the motor fixing supporting seat are connected by the belt pulley transmission device; the energy storage springs areis connected with a ball screw nut; and the energy storage rubber rings are connected with the joint bearings and the joint supporting seats through a shaft. The ankle joint prosthesis provided by the invention not only can completely provide required energy for human gait, but also can adapt to various landforms; in addition, the ankle joint prosthesis can completely imitate movement angles of a human ankle joint on a sagittal plane or a coronal plane; and therefore, the normal walking requirement of an amputation patient can be satisfied better.
Owner:SHANGHAI JIAO TONG UNIV

Use of pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention

ActiveUS20050107294A1Prevents amputationAssisting in limb preservationOrganic active ingredientsPowder deliveryAngiologyDiabetic foot
The invention relates to the use of Epidermal Growth Factor (EGF) in a preferably-injectable pharmaceutical composition which is administered by means of infiltration into and around chronic cutaneous ischaemic lesions in order to prevent diabetic foot amputation. Said composition can be administered to recently-created surgical surfaces damaged by the effect of acute reperfusion with oxygenated blood following prolonged ischaemia, thereby preventing further surgical procedures and favouring the preservation of the extremity. The aforementioned composition can be used to improve (i) the cell microenvironment, thereby increasing the reparative and defensive capacity and viability of the is tissues and (ii) the cicatrisation of cutaneous ischaemic lesions, thereby stimulating cell proliferation. The invention is suitable for use in human, veterinary and experimental medicine, specifically in vascular angiology and surgery, dermatology, burn treatment and reconstructive surgery and geriatric medicine. Said composition can be used for recalcitrant ulcers which are associated with lesions in the macro and/or microvasculature, patients with inadequate lymphatic and/or venous return and ulcers or other lesions which are difficult to cicatrise and/or heal.
Owner:CENT DE ING GENETICA & BIOTECNOLOGIA

Hand and foot bone defect implant

ActiveCN105662655AAvoid the risk of amputationSome functions are reservedBone implantFoot BonesBone marrow cavity
The invention provides a hand and foot bone defect implant which comprises a defect compensation body and two supporting bodies. The defect compensation body comprises a central rod and an outer sleeve fixedly arranged on the central rod in a sleeving mode. The two ends of the central rod can be inserted in medullary cavities of broken bone on the two sides respectively. The end faces of the two ends of the outer sleeve can be connected with fracture surfaces of the broken bone on the two sides respectively. Cavities used for containing filler are formed in the end faces of the two ends of the outer sleeve. At least one part of the surface of the cavity on each end face is attached to the surface of cortical bone of the corresponding connected broken bone so that the corresponding filler can make contact with the cortical bone. The two supporting bodies are connected with the ends of the central rod respectively. The supporting bodies can make contact with the inner walls of the medullary cavities to support the central rod when the two ends of the central rod are inserted in the medullary cavities of the broken bone. By means of the hand and foot bone defect implant, hand and foot bone defect injuries can be repaired, and therefore the original length of the broken bone can be kept, the risk of amputation is avoided, and part of functions can be kept.
Owner:张黎 +1

Traditional Chinese medicine for curing diabetic foot

The invention provides a traditional Chinese medicine for curing diabetic foot, in particular a prescription curing diabetic feet of patients having different courses of the disease and different symptoms by stages. The traditional Chinese medicine is prepared from astragalus root, leatherleaf milletia, white peony root, cassia twig, achyranthes root, red sage root, mulberry twigs, Chinese angelica root, licorice, chuanxiong rhizome, ricepaper pith, asarum herb, sweetgum fruit, dried ginger, prepared rehmannia root, antler gelatin, Chinese ephedra, white mustard seed, Chinese date and other Chinese herbs. The prescription has the advantages that the price is low, the applicability is high, no toxic or side effects are caused, and the like. Successful development of the traditional Chinese medicine fills the gap in the field of medicament for curing diabetic feet, and the traditional Chinese medicine is proved to have good effects through clinical application. When in use, the traditional Chinese medicine can be selectively used according to medical histories and symptoms of the patients, so that symptomatic treatment is realized, the traditional Chinese medicine brings good news for the diabetic foot patients, the disease can be relieved without amputation, and the suffering of 'sugar poison' is eliminated.
Owner:王桂菊

Medicament for treating diabetic complications and preparation method thereof

The invention discloses a medicament for treating diabetic complications and a preparation method thereof. The medicament is mainly prepared from astragalus, polygonum orientale, gypsum, honeysuckle, figwort root, szechwon tangshen root, Chinese angelica, rehmanniae praeparatum, cassia bark, Indian buead, large-headed atractylodes rhizome, white paeony root, plantain seed, raw cinnamomvine, notoginseng root and liquorice root according to a certain weight ratio, and can be prepared into any common formulations. The medicament of the invention has obvious curative effect on the treatment of the diabetic complications and obvious effect of antidiabetics, promotes blood circulation, absorbs extravasated blood of fundus quickly, rehabilitates blood vessels and restores vision. In addition, for patients who suffer from gangrene, the medicament can eliminate polyneuropathy, invigorate podiatric thrombus quickly to form normal blood circulation and cure wounds, and the patients do not need amputation; and the diabetic complications become effective completely within one month, the cure rate of fundus hemorrhage (before laser treatment) within three months is 88 percent, the cure rate of nephropathy is 82 percent, the cure rate of the polyneuropathy is 85 percent, the cure rate of the gangrene is 89 percent, and the comprehensive cure rate of other symptoms is 84 percent. Until now, the diabetic complications are difficult to relapse from the follow-up period, and the medicament is well received by the patients.
Owner:李冠祥

Methods for enhancing healing of diabetic foot ulcers by injecting epidermal growth factor (EGF)

InactiveUS7465704B2Prevents amputationAssisting in limb preservationOrganic active ingredientsPowder deliveryAngiologySurgical department
The invention relates to the use of Epidermal Growth Factor (EGF) in a preferably-injectable pharmaceutical composition which is administered by means of infiltration into and around chronic cutaneous ischaemic lesions in order to prevent diabetic foot amputation. Said composition can be administered to recently-created surgical surfaces damaged by the effect of acute reperfusion with oxygenated blood following prolonged ischaemia, thereby preventing further surgical procedures and favouring the preservation of the extremity. The aforementioned composition can be used to improve (i) the cell microenvironment, thereby increasing the reparative and defensive capacity and viability of the is tissues and (ii) the cicatrisation of cutaneous ischaemic lesions, thereby stimulating cell proliferation. The invention is suitable for use in human, veterinary and experimental medicine, specifically in vascular angiology and surgery, dermatology, burn treatment and reconstructive surgery and geriatric medicine. Said composition can be used for recalcitrant ulcers which are associated with lesions in the macro and / or microvasculature, patients with inadequate lymphatic and / or venous return and ulcers or other lesions which are difficult to cicatrise and / or heal.
Owner:CENT DE ING GENETICA & BIOTECNOLOGIA

Bionic mechanical prosthetic hand driven by wrist joint

InactiveCN101879101ASimple structureReduce weightArtificial handsMetacarpal amputationLarge joint
The invention relates to a bionic mechanical prosthetic hand driven by a wrist joint, comprising a wrist module, a metacarpal joint module and a plurality of finger mechanisms. Each finger mechanism comprises a first knuckle, a second knuckle, a third knuckle, a facet joint knuckle connecting rod and a large joint knuckle connecting rod, wherein one end of the first knuckle is respectively connected with the facet joint knuckle connecting rod and the second knuckle, one end of the second knuckle is respectively connected with the large joint knuckle connecting rod and the third knuckle, one end of the third knuckle is connected with a through-going shaft, one end of the large joint knuckle connecting rod is connected with the driving rod of the wrist joint, the other end is connected with the facet joint knuckle connecting rod; and the wrist module comprises a wrist joint drive rod, a wrist connecting block and a wrist fixing ring, the wrist fixing ring fixed on the wrist is connected with the wrist connecting block rotatably through a connecting shaft. The prosthetic hand not only has the flexion and extension function of human fingers, and has grasping and kneading functions. The device is small and exquisite, and the appearance is close to the size of human fingers, so that the bionic mechanical prosthetic hand is suitable for patients with metacarpal amputation or high phalanx amputation to wear.
Owner:UNIV OF SHANGHAI FOR SCI & TECH

Lower limb prosthesis road condition recognition method based on surface electromyogram signals

The invention provides a lower limb prosthesis road condition recognition method based on surface electromyogram signals. The method comprises the following steps of 1, collecting and preprocessing the lower limb surface electromyogram signals of a thigh amputation patient under different road conditions; 2, extracting a characteristic value sample set of road condition recognition of the preprocessed lower limb surface electromyogram signals; 3, optimizing classification parameters of the extreme learning machine through a backbone particle swarm algorithm to obtain an optimal ELM classifier,and realizing lower limb prosthesis road condition identification and classification. According to the lower limb prosthesis road condition recognition method based on surface electromyogram signals,an extreme learning machine classifier is constructed by using the optimal hidden layer node number and the kernel function parameters. The road condition recognition accuracy is high. The backbone particle swarm algorithm has global search capability, is easy to implement and high in search speed. The premature phenomenon can be effectively avoided on the premise of ensuring the accuracy. The road condition recognition accuracy is effectively improved.
Owner:ZHENGZHOU UNIVERSITY OF LIGHT INDUSTRY

Micropowder medicament for treating bone fractures and preparation method thereof

The invention relates to a micropowder medicament for treating bone fractures such as fracture, paralysis, osteonecrosis and bone fracture sequelae which are caused by trauma and the like and a preparation method thereof. The micropowder medicament comprises the following raw material medicaments: 4 to 7 parts of pyrite, 2 to 5 parts of herry rhodiola, 2 to 5 parts of frankincense, 2 to 5 parts of myrrh, 1 to 5 parts of safflower, 1 to 4 parts of garden balsam stem, 3 to 5 parts of prepared rhubarb, 2 to 5 parts of dioscorea nipponica, 3 to 6 parts of sea cucumber, 1 to 2 parts of gecko tail,3 to 7 parts of pyrolusite and the like. The preparation method comprises the step of grinding the raw material medicaments into fine powder with the grain diameter of 300 to 1,000 meshes by a low-temperature freeze drying method, and preparing capsules for oral administration, or blending on site to form paste for external application; moreover, the medicament can be used for oral administrationand external application simultaneously. The micropowder medicament has the excellent effect on closed fracture except for head injury, and particularly for traumatic patients who suffer from the bone fractures, both the trauma and the bone fractures can be treated. By the invention, more patients who suffer from the bone fractures and particularly serious patients do not suffer from amputation, do not need wheelchairs, and are recovered quickly, without sequela.
Owner:张智富 +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products